Conclusion :
Pediatric CML is a serious hematologic malignancy whose differential diagnosis can be difficult because of the clinical and biological similarities, particularly with atypical CML. Early diagnosis and treatment of juvenile chronic myeloid leukemia allows for better stabilization of the disease, especially with the advent of tyrosine kinase inhibitors, whose discovery was the key to treating pediatric CML.